1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt has been researched along with Acute Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ateyya, H; El-Sherbeeny, NA; Wagih, HM | 1 |
Benoist, M; Busson, J; Cauchoix, J; Deburge, A; Heripret, G; Rigot, J | 1 |
Malecha, SE; Mayor, GH | 1 |
Follett, KA; Maves, TJ; Moore, SA; Rich, G; Sawin, PD; Smith, BA; Traynelis, VC | 1 |
Hadler, NM; Quinet, RJ | 1 |
Anderson, BA | 1 |
Buckley, J; Gibson, MJ; Mulholland, RC; Worthington, BS | 1 |
1 review(s) available for 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Acute Disease
Article | Year |
---|---|
Diagnosis and treatment of backache.
Topics: Acute Disease; Adrenal Cortex Hormones; Back Pain; Braces; Chymopapain; Clinical Trials as Topic; Emergencies; Exercise Therapy; Humans; Injections; Intervertebral Disc; Manipulation, Orthopedic; Muscle Relaxants, Central; Physical Therapy Modalities; Radiography; Spinal Diseases; Traction | 1979 |
1 trial(s) available for 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Acute Disease
Article | Year |
---|---|
Diagnosis and treatment of backache.
Topics: Acute Disease; Adrenal Cortex Hormones; Back Pain; Braces; Chymopapain; Clinical Trials as Topic; Emergencies; Exercise Therapy; Humans; Injections; Intervertebral Disc; Manipulation, Orthopedic; Muscle Relaxants, Central; Physical Therapy Modalities; Radiography; Spinal Diseases; Traction | 1979 |
6 other study(ies) available for 1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt and Acute Disease
Article | Year |
---|---|
Effect of tiron on remote organ injury in rats with severe acute pancreatitis induced by L-arginine.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acute Disease; Animals; Antioxidants; Arginine; Biomarkers; Cytoprotection; Disease Models, Animal; Glutathione; Kidney; Lipid Peroxidation; Liver; Lung; Male; Malondialdehyde; Multiple Organ Failure; NF-kappa B; Nitric Oxide; Oxidative Stress; Pancreas; Pancreatitis; Rats, Wistar; Severity of Illness Index; Superoxide Dismutase; Transforming Growth Factor beta1 | 2016 |
[Treatment of disk sciatica by chemonucleolysis. 120 cases].
Topics: Acute Disease; Adolescent; Adult; Aged; Chymopapain; Endopeptidases; Female; Humans; Injections; Intervertebral Disc Displacement; Male; Middle Aged; Sciatica | 1982 |
Residual chymopapain activity after chemonucleolysis in normal intervertebral discs in dogs.
Topics: Acute Disease; Animals; Chymopapain; Dogs; Humans; Intervertebral Disc Chemolysis; Myelitis, Transverse | 1993 |
Chymopapain-induced reduction of proinflammatory phospholipase A2 activity and amelioration of neuropathic behavioral changes in an in vivo model of acute sciatica.
Topics: Acute Disease; Animals; Behavior, Animal; Chymopapain; Inflammation Mediators; Male; Phospholipases A; Phospholipases A2; Rats; Rats, Inbred F344; Sciatic Nerve; Sciatica | 1997 |
Acute encephalopathy and third-nerve palsy after chymopapain injection.
Topics: Acute Disease; Adult; Chymopapain; Humans; Intervertebral Disc Chemolysis; Male; Meningitis; Meningitis, Aseptic; Ophthalmoplegia | 1988 |
The changes in the intervertebral disc after chemonucleolysis demonstrated by magnetic resonance imaging.
Topics: Acute Disease; Adolescent; Adult; Chymopapain; Female; Humans; Intervertebral Disc; Intervertebral Disc Chemolysis; Intervertebral Disc Displacement; Magnetic Resonance Spectroscopy; Male; Prospective Studies; Sciatica; Time Factors | 1986 |